跳至主要内容
临床试验/CTRI/2024/03/064877
CTRI/2024/03/064877尚未招募4 期

A Randomised Control Trial to compare efficacy of Terlipressin plus Albumin vs Midodrine, Octreotide plus Albumin in the Treatment of Hepatorenal Syndrome . - Nil

Ananya Sharma0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Patient 18 years or older of both sexes
  • 2)Patients diagnosed with HRS

排除标准

  • 1)Contraindications to Terlipressin
  • 2)Patients diagnosed with chronic kidney disease
  • 3)Child Pugh Score more than 13
  • 4)Ongoing shock or uncontrolled bacterial infection
  • 5)Current or recent treatment with nephrotoxic drugs
  • 6)Presence of cardiovascular diseases and any extra hepatic diseases that could affect the short term prognosis

研究者

发起方
Ananya Sharma

相似试验